Louis Moore Bacon's RGEN Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 145,000 shares of Repligen Corporation (RGEN) worth $19.38 M, representing 0.27% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in RGEN, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 95,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Repligen Corporation (RGEN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Repligen Corporation (RGEN) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2023 | +25,000 | New Buy | 25,000 | $159.01 |
| Q4 2023 | +10,000 | Add 40.00% | 35,000 | $179.80 |
| Q1 2024 | -35,000 | Sold Out | 35,000 | $0.00 |
| Q2 2024 | +50,000 | New Buy | 50,000 | $126.06 |
| Q3 2024 | -50,000 | Sold Out | 50,000 | $0.00 |
| Q3 2025 | +145,000 | New Buy | 145,000 | $133.67 |
Louis Moore Bacon's Repligen Corporation Investment FAQs
Louis Moore Bacon first purchased Repligen Corporation (RGEN) in Q3 2023, acquiring 25,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Repligen Corporation (RGEN) for 9 quarters since Q3 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Repligen Corporation (RGEN) was in Q3 2025, adding 145,000 shares worth $19.38 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 145,000 shares of Repligen Corporation (RGEN), valued at approximately $19.38 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Repligen Corporation (RGEN) represents approximately 0.27% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Repligen Corporation (RGEN) was 145,000 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.